Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

ACRS holding history

Aclaris Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACRS overviewAll 13F holders of ACRSFull Q2 2026 holdings

Shares (Q2 2026)
817,531
Value
$4.32M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ACRS by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026817,531$4.32M<0.1%+314,900+62.7%AddedHolders
Q1 2026502,631$1.88M<0.1%−622,700−55.3%ReducedHolders
Q4 20251,125,331$3.39M<0.1%−494,400−30.5%ReducedHolders
Q3 20251,619,731$3.08M<0.1%+154,953+10.6%AddedHolders
Q2 20251,464,778$2.08M<0.1%+513,384+54.0%AddedHolders
Q1 2025951,394$1.46M<0.1%+100,875+11.9%AddedHolders
Q4 2024850,519$2.11M<0.1%−520,181−38.0%ReducedHolders
Q3 20241,370,700$1.58M<0.1%+448,500+48.6%AddedHolders
Q2 2024922,200$1.01M<0.1%−751,200−44.9%ReducedHolders
Q1 20241,673,400$2.08M<0.1%−73,032−4.2%ReducedHolders
Q4 20231,746,432$1.83M<0.1%+1,098,780+169.7%AddedHolders
Q3 2023647,652$4.44M<0.1%−321,900−33.2%ReducedHolders
Q2 2023969,552$10.1M<0.1%−282,600−22.6%ReducedHolders
Q1 20231,252,152$10.1M<0.1%+130,400+11.6%AddedHolders
Q4 20221,121,752$17.7M<0.1%−63,426−5.4%ReducedHolders
Q3 20221,185,178$18.7M<0.1%−144,500−10.9%ReducedHolders
Q2 20221,329,678$18.6M<0.1%−127,900−8.8%ReducedHolders
Q1 20221,457,578$25.1M<0.1%−219,300−13.1%ReducedHolders
Q4 20211,676,878$24.4M<0.1%−344,000−17.0%ReducedHolders
Q3 20212,020,878$36.4M<0.1%−411,000−16.9%ReducedHolders
Q2 20212,431,878$42.7M0.1%−554,600−18.6%ReducedHolders
Q1 20212,986,478$75.3M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.